Evidence map›Paper›PMID 23086146›Full record

ArticleNature2012

Structure of the chemokine receptor CXCR1 in phospholipid bilayers.

Sang Ho Park, Bibhuti B Das, Fabio Casagrande, Ye Tian, Henry J Nothnagel, Mignon Chu, Hans Kiefer, Klaus Maier, Anna A De Angelis, Francesca M Marassi and 1 more

Abstract read
In one paragraph

Article in Nature, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 227 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
227citing papers in PubMed, 1 pooled it
25.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

227 citing papers in PubMed, 1 synthesis or guideline pooled it, 449 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. A novel anti-mouse CXCR1 monoclonal antibody, CxBiochemistry and biophysics reports · 2025
    Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Therapeutic inhibition of CXCR1/2: where do we stand?Internal and emergency medicine · 2023
    Review
  17. Article
  18. Article
  19. Article
  20. Article

167 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Sang Ho ParkDepartment of Chemistry and Biochemistry, University of California, San Diego, 9500 Gilman Drive, La Jolla, California 92093-0307, USA.
Bibhuti B Das
Fabio Casagrande
Ye Tian
Henry J Nothnagel
Mignon Chu
Hans Kiefer
Klaus Maier
Anna A De Angelis
Francesca M Marassi
Stanley J Opella
University of California, San Diego · USMembrane Technology & Research (United States) · USSanford Burnham Prebys Medical Discovery Institute · USUniversity of Applied Sciences Biberach · DE

Funding

RESOURCE FOR SOLID STATE NMR OF PROTEINSP41EB002031 · NIBIB · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI OPELLA, STANLEY J · 2003 to 2018
$16.3M
Target IdentificationP01AI074805 · NIAID · FLORIDA STATE UNIVERSITY · PI CROSS, TIMOTHY A · 2009 to 2013
$8.7M
Molecular Imaging of G-Protein-Coupled Receptors for Drug DevelopmentR01EB005161 · NIBIB · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI OPELLA, STANLEY J · 2006 to 2014
$6.8M
Membrane Protein Structures:Phospholipid Bilayers (RMI)R01GM075877 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI OPELLA, STANLEY J · 2005 to 2009
$1.4M
Structure Determination of Membrane Proteins in Phospholipid BilyaersR01GM099986 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI OPELLA, STANLEY J · 2012 to 2015
$1.1M
Computational methods for NMR structure determination of proteins in membranesR21GM094727 · NIGMS · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI MARASSI, FRANCESCA M · 2010 to 2011
$509k
Structure of- beta barrel membrane protein-lipid bi(RMI)R21GM075917 · NIGMS · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI MARASSI, FRANCESCA M · 2005 to 2006
$474k
NIAID NIH HHS P01 AI074805NIAID NIH HHS P01AI074805NIBIB NIH HHS P41 EB002031NIBIB NIH HHS P41EB002031NIBIB NIH HHS R01 EB005161NIBIB NIH HHS R01EB005161NIGMS NIH HHS R01 GM075877NIGMS NIH HHS R01GM075877NIGMS NIH HHS R01 GM099986NIGMS NIH HHS R21 GM075917NIGMS NIH HHS R21GM075917NIGMS NIH HHS R21 GM094727NIGMS NIH HHS R21GM94727
6 · The paper itself

Abstract

CXCR1 is one of two high-affinity receptors for the CXC chemokine interleukin-8 (IL-8), a major mediator of immune and inflammatory responses implicated in many disorders, including tumour growth. IL-8, released in response to inflammatory stimuli, binds to the extracellular side of CXCR1. The ligand-activated intracellular signalling pathways result in neutrophil migration to the site of inflammation. CXCR1 is a class A, rhodopsin-like G-protein-coupled receptor (GPCR), the largest class of integral membrane proteins responsible for cellular signal transduction and targeted as drug receptors. Despite its importance, the molecular mechanism of CXCR1 signal transduction is poorly understood owing to the limited structural information available. Recent structural determination of GPCRs has advanced by modifying the receptors with stabilizing mutations, insertion of the protein T4 lysozyme and truncations of their amino acid sequences, as well as addition of stabilizing antibodies and small molecules that facilitate crystallization in cubic phase monoolein mixtures. The intracellular loops of GPCRs are crucial for G-protein interactions, and activation of CXCR1 involves both amino-terminal residues and extracellular loops. Our previous nuclear magnetic resonance studies indicate that IL-8 binding to the N-terminal residues is mediated by the membrane, underscoring the importance of the phospholipid bilayer for physiological activity. Here we report the three-dimensional structure of human CXCR1 determined by NMR spectroscopy. The receptor is in liquid crystalline phospholipid bilayers, without modification of its amino acid sequence and under physiological conditions. Features important for intracellular G-protein activation and signal transduction are revealed. The structure of human CXCR1 in a lipid bilayer should help to facilitate the discovery of new compounds that interact with GPCRs and combat diseases such as breast cancer.

Indexed as

DisulfidesEnzyme ActivationHeterotrimeric GTP-Binding ProteinsHumansInterleukin-8Lipid BilayersModels, MolecularMolecular ConformationNuclear Magnetic Resonance, BiomolecularPhospholipidsReceptors, Interleukin-8ASignal TransductionDisulfidesHeterotrimeric GTP-Binding ProteinsInterleukin-8Lipid BilayersPhospholipidsReceptors, Interleukin-8A

Identifiers

PMID23086146
PMCPMC3700570
OpenAlexW2097897519

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.